Cork University Hospital

Cork University Hospital’s oncology program is testing innovative therapies for breast cancer. It also evaluates new approaches for lung cancer and advances treatment options for other solid tumours.

• Breast cancer
• Lung cancer
• Prostate cancer
• Ovarian cancer
• Colorectal cancer
• Bladder cancer
• Melanoma
• Head and neck cancer
• Gastric cancer
• Urothelial carcinoma

Trials focus on evaluating targeted agents, immunotherapies and adjuvant strategies to improve survival and quality of life for patients with these malignancies.

The department conducts studies on blood‑related cancers, including acute lymphoblastic leukaemia and multiple myeloma, aiming to discover more effective treatments.

• Acute lymphoblastic leukaemia
• Acute myeloid leukaemia
• Mantle cell lymphoma
• Multiple myeloma
• Myelodysplastic syndromes
• Polycythemia vera
• Myelofibrosis
• Chronic lymphocytic leukemia
• AL amyloidosis

Research includes novel antibodies, cellular therapies and disease‑modifying agents to enhance remission rates and reduce relapse.

Clinical trials address chronic lung conditions such as asthma and chronic obstructive pulmonary disease, as well as emerging infections like COVID‑19.

• Asthma
• Chronic obstructive pulmonary disease
• Cystic fibrosis
• COVID‑19
• Mpox infection
• Severe eosinophilic asthma
• Bronchiectasis
• Idiopathic pulmonary fibrosis
• Respiratory tract infection

The aim is to improve lung function, reduce exacerbations, and evaluate antiviral or anti‑inflammatory therapies for better patient outcomes.

Studies target kidney diseases, with a focus on reducing proteinuria in conditions like IgA nephropathy and exploring treatments for primary membranous nephropathy.

• IgA nephropathy
• Primary membranous nephropathy
• Nephrotic syndrome
• Renal cell carcinoma
• Venous thromboembolism in cancer patients
• Kidney disease associated with multiple myeloma

These trials aim to preserve renal function, decrease protein loss and assess the safety of emerging therapies.

Research includes inflammatory and autoimmune conditions such as polymyalgia rheumatica and atopic dermatitis, testing new biologic agents.

• Polymyalgia rheumatica
• Atopic dermatitis
• Eosinophilic asthma
• Systemic mastocytosis
• Other immune‑mediated diseases

The goal is to evaluate efficacy of immune‑modulating drugs and improve symptom control and disease remission.

Trials focus on gynecologic cancers, including ovarian cancer and cervical cancer, to develop better targeted and adjuvant therapies.

• Ovarian cancer
• Fallopian tube cancer
• Cervical cancer
• Endometrial cancer
• High‑risk HER2‑positive breast cancer (female cohort)
• Pregnancy‑related complications

These studies aim to improve survival, reduce recurrence and personalize treatment for women affected by these conditions.